seed
Stage
2
Investors
About
Montara Therapeutics develops brain-selective therapies for central nervous system diseases using its proprietary BrainOnly™ platform, which pairs brain-penetrant drugs with peripheral blockers to prevent off-target effects.
Explore Montara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.